Search Results
Viewing: 41-50 of 320 | All
News
Nationwide Children’s Hospital Renames Center for Gene Therapy, Honoring Jerry Mendell, MD
Nationwide Children’s Hospital announced today the renaming and dedication of the Jerry R. Mendell, MD Center for Gene Therapy at the Abigail Wexner Research Institute, in honor of Jerry Mendell, MD, a pioneer in the fields of neurology and gene therapy and a catalyst for advancement in the treatment of multiple neuromuscular disorders.
Specialty
Hematology
The Comprehensive Hemophilia and Bleeding Disorder Treatment Center at Nationwide Children's is the largest and only federally recognized pediatric Hemophilia Treatment Center (HTC) in Central Ohio. Our board certified hematologists and team will diagnose and treat your child in an environment where cutting edge advancements in blood disorders are taking place.
News
Jaimie D. Nathan, MD, Achieves Surgical Milestone: 100th TPIAT Procedure
Nationwide Children’s Hospital congratulates Jaimie D. Nathan, MD, on a significant milestone in an advanced procedure known as a total pancreatectomy with islet autotransplantation (TPIAT). Dr. Nathan performed his 100th TPIAT on September 19, 2023.
Specialty
Hydrocephalus Program
At Nationwide Children’s Hospital, the Hydrocephalus Program cares for children with hydrocephalus at every stage — from before birth through young adulthood. Led by Albert M. Isaacs, MD, PhD, a nationally recognized leader in pediatric hydrocephalus care and research, our team brings together experts from multiple specialties to deliver coordinated, personalized treatment.
Article
Khalsa Lab Staff
Learn more about principal investigator Amrik Singh Khalsa, MD, and his dynamic team in the Khalsa Lab.
News
New Initiative Aims to Improve Diagnosis and Treatment of Children with Solid Tumors Through Molecular Analysis
The National Cancer Institute (NCI), part of the National Institutes of Health, Children’s Oncology Group (COG), and Nationwide Children's Hospital are poised to change the direction of pediatric cancer diagnosis and care. New results from international efforts to characterize pediatric cancers have led to the Molecular Characterization Initiative: a project that aims to collect, analyze, and report clinical molecular data to support COG-affiliated clinicians in choosing the best treatment for each child. This program is part of the NCI Childhood Cancer Data Initiative (CCDI).
Article
Dennis R. Durbin
Dennis R. Durbin, MD, MSCE, is president of the Abigail Wexner Research Institute (AWRI) at Nationwide Children’s Hospital, a professor of Pediatrics at The Ohio State University College of Medicine and vice chair for Research in the Department of Pediatrics.
Specialty
Liver Care (Hepatology)
Our center is an integral part of the Division of Gastroenterology, Hepatology and Nutrition at Nationwide Children’s, caring for a wide range of liver diseases through medical management and surgery.
News
Nationwide Children's Hospital Ranked Among Top Hospitals in Ohio on Forbes List of “America’s Best Employers”
Nationwide Children’s Hospital has been named one of “America’s Best Employers” by Forbes for the fifth consecutive year.
News
FDA Approves First Gene Therapy Treatment for Duchenne Muscular Dystrophy Developed at the Abigail Wexner Research Institute at Nationwide Children’s Hospital
Today, the Abigail Wexner Research Institute at Nationwide Children’s Hospital praised the Food and Drug Administration (FDA) for its accelerated approval of SRP-9001/ELEVIDYS for Duchenne muscular dystrophy (DMD) following decades of research in its Center for Gene Therapy to help patients with neuromuscular diseases.